Kraig gets fund for recombinant spider silk production

13 Mar '19

1 min read

Kraig Biocraft Laboratories has closed a $1 million round of private financing, pursuant to Regulation S of the Securities Act of 1933, as amended. The fund is for expansion is for its recombinant spider silk production in Vietnam, support its advanced research operations, improve its balance sheet, and to support other corporate initiatives.

A core focus for this funding will be to support the growth of operations at the company’s new production facility in Quang Nam Province, Vietnam. With this funding in place, the company plans to ramp up its silk production at this larger factory.

"Securing this bridge financing was a key piece to funding the Company’s commercial expansion strategy and puts us in a strong position as we expand spider silk production we shift operational focus to production," said COO Jon Rice. "This capital is necessary to support commercial expansion, which is essential in establishing market channel collaborations for consumer products."

Under the terms of the stock purchase agreement, the company has issued shares of its class A common stock at a price of $0.06758 per share and warrants to purchase additional shares of its class A common stock at exercise prices of $0.06 and $0.08. (RR)

Fibre2Fashion News Desk – India

More Textiles News - United States Of America...